1. Home
  2. FUL vs ZLAB Comparison

FUL vs ZLAB Comparison

Compare FUL & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H. B. Fuller Company

FUL

H. B. Fuller Company

HOLD

Current Price

$60.17

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$25.49

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUL
ZLAB
Founded
1887
2013
Country
United States
China
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
FUL
ZLAB
Price
$60.17
$25.49
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$68.40
$49.60
AVG Volume (30 Days)
570.1K
851.0K
Earning Date
03-25-2026
05-07-2026
Dividend Yield
1.57%
N/A
EPS Growth
19.57
38.46
EPS
1.61
N/A
Revenue
$2,897,000,000.00
$460,156,000.00
Revenue This Year
$4.96
$9.75
Revenue Next Year
$4.00
$26.03
P/E Ratio
$38.53
N/A
Revenue Growth
N/A
15.33
52 Week Low
$48.71
$15.96
52 Week High
$68.63
$36.77

Technical Indicators

Market Signals
Indicator
FUL
ZLAB
Relative Strength Index (RSI) 58.26 76.57
Support Level $58.21 $16.98
Resistance Level $62.04 $27.23
Average True Range (ATR) 1.63 1.10
MACD 0.72 0.75
Stochastic Oscillator 75.11 85.87

Price Performance

Historical Comparison
FUL
ZLAB

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: